The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abcellera Biologics Inc. | COM | 00288U106 | 805 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ALX Oncology Holdings Inc. | COM | 00166B105 | 27,584 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| BCTG Acquisition Corp. | COM | 05492W103 | 4,576 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Consonance-HFW Acquisition Corp. | UNIT | 0G244M129 | 1,047 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| Helix Acquisition Corp. | COM CL A | G4444C102 | 2,843 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| Kinnate Biopharma Inc. | COM | 49705R105 | 34,808 | 875,001 | SH | SOLE | 875,001 | 0 | 0 | ||
| LifeSci Acquisition II Corp. | COM | 53229E103 | 4,268 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Nurix Therapeutics, Inc. | COM | 67080M103 | 14,846 | 451,522 | SH | SOLE | 451,522 | 0 | 0 | ||
| Oaktree Acquisition Corp. | SHS CL A | G67145105 | 12,723 | 871,422 | SH | SOLE | 871,422 | 0 | 0 | ||
| Population Health Investment Co., Inc. | UNIT | G71716123 | 10,032 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
| Relay Therapeutics, Inc. | COM | 75943R102 | 16,624 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | 4,872 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||